About 253,000 results
- People also ask
- The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.www.cnn.com/2024/06/20/health/fda-gene-therapy-duchenne-muscular-dystrop…
FDA expands approval of first gene therapy for rare form of …
Muscular dystrophy patients get first gene therapy - NPR
FDA approves $3.2 million gene therapy for rare muscular …
FDA advisers narrowly vote in favor of experimental gene therapy …
FDA Approves First Gene Therapy for Treatment of Certain …
FDA Expands Approval of Gene Therapy for Patients with …
FDA Duchenne muscular dystrophy gene therapy : …
WEBMay 12, 2023 · A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.
FDA Approves Nonsteroidal Treatment for Duchenne Muscular …
First gene therapy for deadly form of muscular dystrophy gets FDA ...
‘It’s a vote for hope’: first gene therapy for muscular …
WEBJun 2, 2023 · Update: The US Food and Drug Administration has now approved the first gene therapy for Duchenne muscular dystrophy for children aged four and five. The one-time treatment, named Elevidys, …
Related searches for duchenne muscular dystrophy news